Feed Navigator: Akeso Patent Looks to Offer Antibiotic-free Alternative for Campylobacter Reduction
By Aerin Einstein-Curtis

Akeso Biomedical has received a US patent covering some of its work to reduce the presence of the bacterium campylobacter in poultry using an antibiotic-free feed additive, says COO.


Akeso Biomedical™ Advances Technology to Reduce Foodborne Illness; Receives New Patent to Reduce Campylobacter Infections

Patent No. US 9,655,912 B2 titled “Reduction of Gastrointestinal Tract Colonization by Campylobacter”


Akeso Biomedical™ Closes Financing Round of $4.4M

Funding for the Commercial Launch of Feed Additives for Poultry and Piglets to Combat Foodborne Illnesses and Improve Animal Microbiomes

JUNE 2017

Akeso's non-antibiotic feed additive targets Campylobacter in Europe

By Joseph Harvey, Animal Pharm News

JUNE 2017

Feed Navigator: Start-up Targets EU with Poultry Feed Additive Product Lacking US Market Understanding
By David Anderson

A US start-up is launching its debut feed additive product designed to reduce the effect of harmful bacteria in the EU ahead of the US, as the US lags behind Europe in understanding and controlling campylobacter, says COO.

JUNE 2017

Akeso Biomedical™ Files TYPLEX™ Chelate Dossier to Reduce Campylobacter in EU Poultry

Significant reductions of enteropathogens in the GI tracts of broilers – by up to 3 log CFUs/gram in caeca

MAY 2017

Akeso Biomedical™ Appoints Scott Roth to its Board of Directors

Hedge fund manager to bring extensive financial expertise to the board.


Akeso Biomedical Appoints Greg W. Lee to Board of Directors

Former president of Tyson Foods International to help commercialize food safety technology.

MARCH 2016

The Top 7 Boston-Area Startups to Watch in 2016

Akeso Biomedical is number four on list.


UK Food Standards Agency Notes Initial Success in Akeso Biomedical and Banham Poultry Trials to Reduce Campylobacter Using Feed Additives


Banham Poultry and Akeso Biomedical Partner to Reduce Foodborne Illness due to Campylobacter

New class of feed additives promises unique solution to Campylobacter.


Akeso Biomedical Enters into License Agreement for Fe3C Compounds to Prevent Foodborne Illness

New class of compounds promises solution to Campylobacter food poisoning.

MAY 2015

Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors

M.I.T. biotechnology professor to help expand Company’s technical portfolio and seek new solutions for treatment of bacterial infections and biofilms.